A randomized comparison of once- versus twice-daily Mmx® mesalamine for the maintenance of remission in mild-to-moderate ulcerative colitis

被引：0
|
作者：
Kamm, Michael A.
Colombel, Jean-frederic
Kornbluth, Asher
Diebold, Ron
Barrett, Karen
Karlstadt, Robyn G.
Joseph, Raymond E.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A510 / A510
页数：1
相关论文
共 50 条
  • [41] MMX® mesalamine treatment for patients with mild-to-moderate ulcerative colitis: improvement in health-related quality of life
    Kane, S.
    Yen, L.
    Yarlas, A.
    Karlstadt, R.
    Solomon, D.
    Hodgkins, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A92 - A92
  • [42] Once-versus twice-daily mesalazine (pentasa) granules for the maintenance of remission in ulcerative colitis: Results from a multinational randomised controlled trial
    Dignass, A.
    Veerman, H.
    GUT, 2008, 57 : A1 - A1
  • [43] Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
    Travis, Simon P. L.
    Danese, Silvio
    Kupcinskas, Limas
    Alexeeva, Olga
    D'Haens, Geert
    Gibson, Peter R.
    Moro, Luigi
    Jones, Richard
    Ballard, E. David
    Masure, Johan
    Rossini, Matteo
    Sandborn, William J.
    GUT, 2014, 63 (03) : 433 - 441
  • [44] Maintenance of clinical remission with MMX® mesalazine 2.4 g/day in patients with mild-to-moderate ulcerative colitis, irrespective of prior treatment
    Kane, S.
    Solomon, D.
    Palmen, M.
    Barrett, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A91 - A91
  • [45] Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis A Randomized, Placebo-controlled Clinical Trial
    Gordon, Glenn L.
    Zakko, Salam
    Murthy, Uma
    Sedghi, Shahriar
    Pruitt, Ronald
    Barrett, Andrew C.
    Bortey, Enoch
    Paterson, Craig
    Forbes, William P.
    Lichtenstein, Gary R.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 (04) : 318 - 325
  • [46] Psoriasis vulgaris:: Once- versus twice-daily application of calcipotriol cream
    Duweb, G
    Alhaddar, J
    Abuhamida, M
    INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS, 2005, 27 (04): : 155 - 158
  • [47] Once-daily, high-concentration MMX mesalamine in active ulcerative colitis
    Kamm, Michael A.
    Sandborn, William J.
    Gassull, Miguel
    Schreiber, Stefan
    Jackowski, Lechoslaw
    Butler, Todd
    Lyne, Andrew
    Stephenson, David
    Palmen, Mary
    Joseph, Raymond E.
    GASTROENTEROLOGY, 2007, 132 (01) : 66 - 75
  • [48] Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis
    Larsen, Mads Lamm
    Pedersen, Oliver Heidmann
    Hvas, Anne-Mette
    Niekerk, Peter Buur van Kooten
    Bonlokke, Soren
    Kristensen, Steen Dalby
    Grove, Erik Lerkevang
    PLATELETS, 2019, 30 (03) : 322 - 328
  • [49] COMPARISON OF THE SAFETY AND EFFICACY OF ONCE-DAILY TERAZOSIN VERSUS TWICE-DAILY PRAZOSIN FOR THE TREATMENT OF MILD TO MODERATE HYPERTENSION
    DEGER, G
    CUTLER, RE
    DIETZ, AJ
    LEWIN, AJ
    VLACHAKIS, N
    AMERICAN JOURNAL OF MEDICINE, 1986, 80 (5B): : 62 - 67
  • [50] Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine
    Zandman, Daniel B.
    Peppercorn, Mark A.
    PATIENT PREFERENCE AND ADHERENCE, 2009, 3 : 87 - 92
12345